170 related articles for article (PubMed ID: 36279690)
21. Vaginal CO
Jacobsen S; Glavind-Kristensen M; Jensen AB; Forman A; Bor P
BMC Cancer; 2023 Nov; 23(1):1164. PubMed ID: 38031020
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study.
De Seta F; Caruso S; Di Lorenzo G; Romano F; Mirandola M; Nappi RE
Maturitas; 2021 May; 147():34-40. PubMed ID: 33832645
[TBL] [Abstract][Full Text] [Related]
23. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women.
Cruz VL; Steiner ML; Pompei LM; Strufaldi R; Fonseca FLA; Santiago LHS; Wajsfeld T; Fernandes CE
Menopause; 2018 Jan; 25(1):21-28. PubMed ID: 28763401
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
Jha S; Wyld L; Krishnaswamy PH
Clin Breast Cancer; 2019 Aug; 19(4):e556-e562. PubMed ID: 31227415
[TBL] [Abstract][Full Text] [Related]
25. A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause.
Biehl C; Plotsker O; Mirkin S
Menopause; 2019 Apr; 26(4):431-453. PubMed ID: 30363010
[TBL] [Abstract][Full Text] [Related]
26. Vaginal oxygen plus hyaluronic acid on genito-urinary symptoms of breast cancer survivors.
Massarotti C; Asinaro G; Schiaffino MG; Ronzini C; Vacca I; Lambertini M; Anserini P; Del Mastro L; Cagnacci A
Climacteric; 2023 Apr; 26(2):129-134. PubMed ID: 36697389
[TBL] [Abstract][Full Text] [Related]
27. Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment.
Mothes AR; Runnebaum M; Runnebaum IB
J Cancer Res Clin Oncol; 2018 May; 144(5):955-960. PubMed ID: 29487993
[TBL] [Abstract][Full Text] [Related]
28. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel.
Caruso S; Cianci S; Amore FF; Ventura B; Bambili E; Spadola S; Cianci A
Menopause; 2016 Jan; 23(1):47-54. PubMed ID: 26079974
[TBL] [Abstract][Full Text] [Related]
29. Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review.
Buzzaccarini G; Marin L; Noventa M; Vitagliano A; Riva A; Dessole F; Capobianco G; Bordin L; Andrisani A; Ambrosini G
Climacteric; 2021 Dec; 24(6):560-571. PubMed ID: 33759670
[TBL] [Abstract][Full Text] [Related]
30. Monurelle Biogel
Nappi RE; Cagnacci A; Becorpi AM; Nappi C; Paoletti AM; Busacca M; Martella S; Bellafronte M; Tredici Z; Di Carlo C; Corda V; Vignali M; Bagolan M; Sardina M
Climacteric; 2017 Oct; 20(5):467-475. PubMed ID: 28657769
[TBL] [Abstract][Full Text] [Related]
31. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
Labrie F; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; Beauregard A; Martel C; Vaillancourt M; Balser J; Moyneur É;
Menopause; 2016 Mar; 23(3):243-56. PubMed ID: 26731686
[TBL] [Abstract][Full Text] [Related]
33. Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial.
Politano CA; Costa-Paiva L; Aguiar LB; Machado HC; Baccaro LF
Menopause; 2019 Aug; 26(8):833-840. PubMed ID: 31246661
[TBL] [Abstract][Full Text] [Related]
34. Lasers in the era of evidence-based medicine.
Hillard TC
Climacteric; 2020; 23(sup1):S6-S10. PubMed ID: 33124459
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
Fernandes T; Costa-Paiva LH; Pedro AO; Baccaro LF; Pinto-Neto AM
Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462
[TBL] [Abstract][Full Text] [Related]
36. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.
Parsons A; Merritt D; Rosen A; Heath H; Siddhanti S; Plouffe L;
Obstet Gynecol; 2003 Feb; 101(2):346-52. PubMed ID: 12576260
[TBL] [Abstract][Full Text] [Related]
37. Current overview of the management of urogenital atrophy in women with breast cancer.
Pruthi S; Simon JA; Early AP
Breast J; 2011; 17(4):403-8. PubMed ID: 21645165
[TBL] [Abstract][Full Text] [Related]
38. The detection and management of vaginal atrophy.
Johnston SL; Farrell SA; Bouchard C; Farrell SA; Beckerson LA; Comeau M; Johnston SL; Lefebvre G; Papaioannou A;
J Obstet Gynaecol Can; 2004 May; 26(5):503-15. PubMed ID: 15151738
[TBL] [Abstract][Full Text] [Related]
39. The effects of hyaluronic acid vaginal gel on the vaginal epithelium of ovariectomized rats.
Liu SB; Liu SL; Gan XL; Zhou Q; Hu LN
Gynecol Endocrinol; 2015 Mar; 31(3):208-13. PubMed ID: 25366523
[TBL] [Abstract][Full Text] [Related]
40. [Local estrogen therapy--clinical implications--2012 update].
Kokot-Kierepa M; Bartuzi A; Kulik-Rechberger B; Rechberger T
Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
